Lewati ke konten utama
BookOpen AccessTerbit 2022Versi 1

Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin and Aspirin for Stroke Prevention Atrial Fibrillation (SPAF) in the Indonesian healthcare setting

Koleksi Perpustakaan•Fakultas Farmasi UGM•1 dilihat · 0 unduhan

Abstrak

Abstrak belum tersedia pada metadata publik.

Informasi bibliografis

Versi dan riwayat publik

  1. Versi 1Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin and Aspirin for Stroke Prevention Atrial Fibrillation (SPAF) in the Indonesian healthcare setting2022 · oai:ais:library-item:7763